We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Insight into Male Infertility

By Biotechdaily staff writers
Posted on 02 Sep 2003
Researchers have identified a new protein that is required for a sperm to bind to an egg during the process of fertilization, suggesting the cause for some instances of male infertility. More...
The finding was reported in the August 22, 2003, issue of Cell.

In many cases the sperm of infertile men appear to be completely normal. The researchers focused on the specific molecules and events required for a sperm to recognize an egg so that fertilization can take place. They identified a protein on the surface of mouse sperm that is required for the sperm to successfully bind to the outside of the egg. This protein, called SED1, binds specifically to unfertilized eggs, and no longer recognizes an egg after it has been fertilized. In the laboratory, sperm without SED1 were unable to bind to an egg, and mice without SED1 had greatly reduced fertility even though their sperm were normal in number and motility.

"An understanding of the molecular mechanisms underlying sperm-egg binding may give insight into the basis for at least some percentage of male infertility,” explained Barry D. Shur, Ph.D., professor and chair of cell biology at Emory University School of Medicine (Atlanta, GA, USA; www.emory.edu). "In addition, this work is of interest because the composition of SED1 is similar to other types of cell-cell binding proteins, which have not previously been implicated in sperm-egg binding.”




Related Links:
Emory U.

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
HPV Test
Allplex HPV28 Detection
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.